Following up on the success of “Building Biotechnology” (www.BuildingBiotechnology.com), I’m in the late stages of assembling a more advanced follow-up […]

Genentech is investing $140mm in a new biologic manufacturing plant in Singapore. The first commercial-scale microbial fermentation plant in Singapore,

I touched briefly on the Medimmune v. Genentech case in a previous Carnival of Biotechnology, but I didn’t go into

The latest Carnival of Biotechnology is up at Baby Biotechs. Great job, Brian! For more information, see the Carnival of

Just came across an article on diabetics going to Mexico to receive pig xenotransplants. Unlike other forms of medical tourism,

This follow-up to my post on the technical reasons why biogenerics are so hard to regulate provides some updates the

If there’s one sure rule about private equity, it is that there are no rules about private equity! Venture capitalists

Biotechnology companies have been facing a widening funding gap. Between frozen federal research budgets and a growing focus among venture

The United States is the world’s largest pharmaceutical market. Japan is the second largest, although the combined European Union is

Countries use various methods to control drug expenditures. Beyond simple negotiation, countries can also implement price controls or use WTO-authorized